These results suggest that inhibition of LATS could increase the response of CML cells to IM by inducing their erythroid differentiation and increasing apoptosis, which is consistent with a previous report showing that LATS1 and LATS2 decrease as cells mature. Here, LATS1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.